Active ingredient and composition:
Each vial contains:
Sterile Cefotaxime Sodium USP equivalent to Anhydrous Cefotaxime 1000 mg.
Used in the treatment of severe infections caused by Cefotaxime-sensitive pathogens such as: infections of the respiratory tract, including throat and nose, infections of the ear, kidneys and urinary tract infections, skin and soft tissue infections, conditions of the bones and joints, infections in the genital organs and abdominal region, septicaemia, bacterial endocarditis & meningitis. For preoperative prophylaxis in patients who are at increased risk from infection and for the prophylaxis of infections in patients with reduced resistance. Combined treatment: in severe, life-threatening infections, the combination of Cefotaxime Sodium with aminoglycosides is indicated without awaiting the results of sensitivity tests. The two preparations must be administered separately, not mixed in one syringe of infusion bottle. Infections with Pseudomonas aeruginosa may require treatment with other antibiotics effective against Pseudomonas.
CEFOTAZEN-1000 is contraindicated in patients who have shown hypersensitivity to cephalosporins. In patiens hypersensitive to penicillin, the possibility of cross-sensitivity exists. Renal function must be checked in case of use of a combination of CEFOTAZEN with aminoglycosides.
1000 mg vials of Cefotaxime (as Cefotaxime Sodium). Possibility to adapt packing and quantities to customer needs.
For intramuscular or intravenous administration.